Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11 Mars 2025 - 9:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rules 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month of March 2025
Commission File Number: 001-38836
BIOCERES CROP
SOLUTIONS CORP.
(Translation of registrant’s name into English)
Ocampo 210 bis, Predio CCT, Rosario
Province of Santa Fe, Argentina
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Exhibit List
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
BIOCERES CROP SOLUTIONS CORP. |
|
(Registrant) |
|
|
|
Dated: March 11, 2025 |
By: |
/s/ Federico Trucco |
|
Name: |
Federico Trucco |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
Bioceres Crop Solutions Announces
EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management
ROSARIO, Argentina—March
11, 2025 (BUSINESS WIRE) —Bioceres Crop Solutions (NASDAQ: BIOX),
a leading global provider of sustainable crop productivity solutions, and ProFarm Group, a subsidiary of BIOX, today announced that their
innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency
(EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA’s assessment of its negligible risk to human health
and non-target organisms.
Rinotec has already been approved for commercialization
in Brazil. With both U.S. and Brazilian registrations now in place, Bioceres Crop Solutions is poised to advance its regulatory and commercial
strategies in these regions, offering growers a powerful alternative that reduces reliance on traditional chemical pesticides. These
approvals highlight the product’s strong efficacy profile and position Bioceres Crop Solutions to capitalize on growing market
opportunities in two of the world’s largest agricultural economies.
“The EPA’s approval marks a key milestone
in our efforts to bring transformative innovation to growers and the agriculture market,” said Milen Marinov, Chief Commercial
Officer of Bioceres Crop Solutions. “The Rinotec platform is unique in its metabolite-based approach to biologicals, enabling substantial
dose reductions while maintaining the efficiency and consistency of synthetic chemical pesticides. This makes it an ideal solution for
row and specialty crops alike.”
“We are thrilled to achieve this important regulatory
milestone for our new generation crop protection product,” said Federico Trucco, CEO of Bioceres Crop Solutions. “By equipping
farmers with safer, more sustainable pest management solutions, we’re driving meaningful progress toward a more resilient global
food system while maintaining robust productivity and environmental stewardship.”
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a leader in the development
and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate
change. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally
friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial
ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital
solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit
here.
Forward-looking statements
This communication includes “forward-looking
statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,”
“intend,” “seek,” “target,” “anticipate,” “believe,”
“expect,” “estimate,” “plan,” “outlook,” and “project” and other similar
expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking
statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the
Company’s current or future results and future business and economic conditions more generally. Such forward-looking
statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or
achievement of the Company to be materially different from any future results expressed or implied by such forward-looking
statements, and there can be no assurance that actual results will not differ materially from management’s expectations or
could affect the Company’s ability to achieve its strategic goals, including factors that are described in the sections
entitled “Risk Factors” in the Company's Securities and Exchange Commission filings updated from time to time. The
preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on
any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release
are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were
made, and the Company does not intend to update or otherwise revise the forward-looking statements to reflect events or
circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.
Bioceres Crop Solutions
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com
Bioceres Crop Solutions (NASDAQ:BIOX)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Bioceres Crop Solutions (NASDAQ:BIOX)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025